Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome. [electronic resource] by
- Lahiff, C
- Safaie, P
- Awais, A
- Akbari, M
- Gashin, L
- Sheth, S
- Lembo, A
- Leffler, D
- Moss, A C
- Cheifetz, A S
Producer: 20130910
In:
Alimentary pharmacology & therapeutics vol. 37
Availability: No items available.
|
|
18.
|
Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014. [electronic resource] by
- Ballou, S
- Hirsch, W
- Singh, P
- Rangan, V
- Nee, J
- Iturrino, J
- Sommers, T
- Zubiago, J
- Sengupta, N
- Bollom, A
- Jones, M
- Moss, A C
- Flier, S N
- Cheifetz, A S
- Lembo, A
Producer: 20190531
In:
Alimentary pharmacology & therapeutics vol. 47
Availability: No items available.
|
|
19.
|
Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groups. [electronic resource] by
- Cheifetz, A S
- Melmed, G Y
- Spiegel, B
- Talley, J
- Devlin, S M
- Raffals, L
- Irving, P M
- Jones, J
- Kaplan, G G
- Kozuch, P
- Sparrow, M
- Velayos, F
- Baidoo, L
- Bressler, B
- Siegel, C A
Producer: 20130503
In:
Inflammatory bowel diseases vol. 18
Availability: No items available.
|